Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used?
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Enrollment
- 120
- Locations
- 5
- Primary Endpoint
- scale : HAS-Bled
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Atrial fibrillation (AF) is a rhythmic cardiac activity disorder disturbing hemodynamic blood flow. It is a public health problem with 600,000 to 1 million people involved in France which 2/3 are aged over 75 years. a FA untreated exposes the patient to a significant risk of embolism responsible for a rate stroke (stroke) ischemic estimated at 85%. The anticoagulant standard treatment helps prevent the occurrence of this complication.
However, oral anticoagulation also exposes patients to an increased risk of bleeding. The bleeding risk can be assessed using scales: several being proposed (HEMORR2HAGES, HAS-BLED, ATRIA and scores Shireman and Charlson ...).
moreover, in geriatric hospital care, every patient has a "standardized geriatric assessment" to assess and quantify functional capacity, autonomy, cognitive abilities, nutritional status, psychological state and its environment social.
Thus, the objective of the investigators study was to determine the frequency of each item of each bleeding risk assessment score and geriatric assessment in patients 80 and older hospitalized geriatric ward in the department and with anticoagulant.
Investigators
Eligibility Criteria
Inclusion Criteria
- •hospitalisation in geriatric unit
- •Atrial fibrillation treated by anticoagulant treatment (AVK or oral anticoagulation)
- •signed inform consent
Exclusion Criteria
- •estimated lifetime less than 6 months
- •under guardianship or curatorship
- •without support person
Outcomes
Primary Outcomes
scale : HAS-Bled
Time Frame: at baseline
arterial hypertension, renal function, liver function, cerebrovascular accident...
scale : shireman
Time Frame: at baseline
gender, age, hemorrhage, diabetes, anemia...
scale charlson
Time Frame: at baseline
age, cardiovascular disease, lung disease, neurological disease, endocrinal disease, nephrology, liver disease, gastroenterology, cancer
scale : HEMORR2HAGES
Time Frame: at baseline
hepatics diseases, alcoholism, cancer, thrombocytopenia, anemia and antecedent...
scale : ATRIA
Time Frame: at baseline
anemia, serious kidney diseases, hypertension, antecedent...
scale : standardised geriatric assessment
Time Frame: at baseline
comorbidities, cognition, mobility, pain, nutrition, living environment...
Secondary Outcomes
- genotyping(at baseline)
- Occurrence of major bleeding event or not major(at baseline and 6 months)